20 results
8-K
EX-10.2
LYEL
Lyell Immunopharma, Inc.
16 Dec 22
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
4:02pm
, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated
S-3ASR
EX-1.2
7a91 m1j1raahz0t
4 Aug 22
Automatic shelf registration
5:29pm
10-K
EX-10.8
7x0jem8bye2kd31cpv7l
29 Mar 22
Annual report
4:20pm
S-1/A
EX-10.15
8s3d8
9 Jun 21
IPO registration (amended)
7:12am
S-1
EX-10.8
e5nn14 mrcx4
25 May 21
IPO registration
5:28pm
S-1
EX-10.12
wqvkbc
25 May 21
IPO registration
5:28pm
S-1
EX-10.15
1nd9un9u0k4zng5
25 May 21
IPO registration
5:28pm
S-1
EX-10.10
jqeozrlle5frxo0i nbi
25 May 21
IPO registration
5:28pm
S-1
EX-10.16
bgp7xphr p0z
25 May 21
IPO registration
5:28pm
S-1
EX-10.11
kzh7jr0il jno44pz
25 May 21
IPO registration
5:28pm
DRS
EX-10.11
18s9fhf6ugtu168em3b
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.12
e382oi785
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.8
4o8j9
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.10
lc3iv8llhk yz4u3an
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.16
tb3sxv d934ft
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.15
abo2k310gyr
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next